Search for the latest oncology news by tumour type
SABCS 2016 : Adding everolimus to fulvestrant improved outcomes for postmenopausal patients with HR-positive breast cancer
Progression-free survival was more than doubled for patients with metastatic hormone receptor (HR)-positive, HER2-negative breast…